Common use of Compound Safety Issues Clause in Contracts

Compound Safety Issues. Each Party represents and warrants that, to the best of its knowledge as of the Effective Date, it is not aware of any material safety data relating to its Compound, whether alone or in combination with any other agent, that either has not already been communicated to the other Party or is not reflected in the investigator’s brochure for its Compound existing as of the Effective Date.

Appears in 2 contracts

Samples: Trial Collaboration Agreement (Checkmate Pharmaceuticals, Inc.), Trial Collaboration Agreement (Compugen LTD)

AutoNDA by SimpleDocs

Compound Safety Issues. Each Party represents and warrants as of the Effective Date that, to the best of its knowledge as of the Effective Dateknowledge, it is not aware of any material safety data relating issue with respect to its Compound, whether alone or in combination with any other agent, Compound that either has not already been communicated to the other Party or is not reflected in the investigator’s brochure for its Compound existing as of the Effective Date.

Appears in 1 contract

Samples: Clinical Trial Collaboration and Supply Agreement (IDEAYA Biosciences, Inc.)

Compound Safety Issues. Each Party represents and warrants to the other Party that, to the best of its knowledge as of the Effective Date, it is not aware of any material safety data relating to its Compound, whether alone or in combination with any other agent, that either has not already been communicated to the other Party or is not reflected in the investigator’s brochure for its Compound existing as of the Effective Date.

Appears in 1 contract

Samples: Master Clinical Trial Collaboration Agreement (BioAtla, Inc.)

AutoNDA by SimpleDocs

Compound Safety Issues. Each Party represents and warrants that, to the best of its knowledge as of the Effective Dateknowledge, it is not aware of any material safety data relating or toxicity issue with respect to its Compound, whether alone or in combination with any other agent, Compound that either has not already been communicated to the other Party or is not reflected in the investigator’s brochure for its Compound existing as of the Effective Date.

Appears in 1 contract

Samples: Clinical Trial Collaboration Agreement (Turning Point Therapeutics, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.